Evidence map›Paper›PMID 41231873›Full record

ArticlePloS one2025

Aflatoxin contamination of maize flour in Kenya: Results from multi-city, multi-round surveillance.

Vivian Hoffmann, Boaz Ndisio, Allan Barasa, Sheila Okoth, Mike Murphy

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vivian HoffmannInternational Food Policy Research Institute, Washington, DC, United States of America.
Boaz NdisioAsperlabs Limited, Aflatoxin Management Services, Nairobi, Kenya.
Allan BarasaFood Safety Division, Ministry of Health, Nairobi, Kenya.
Sheila OkothDepartment of Biology, Faculty of Science and Technology, University of Nairobi, Nairobi, Kenya.ORCID https://orcid.org/0000-0002-7803-0301
Mike MurphyInternational Food Policy Research Institute, Washington, DC, United States of America.ORCID https://orcid.org/0000-0002-0293-1621

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Foodborne illness is a major source of the global burden of disease, but public monitoring of hazards in food systems is overwhelmingly focused on the formal sector in high income countries. We contribute to the development of an evidence base on food safety risk in low-income and informal settings by monitoring aflatoxin prevalence in maize flour in Kenya. Aflatoxin is a contaminant which causes liver cancer and has been linked to childhood stunting. We carry out systematic monitoring of formally and informally processed maize flour from a range of retail vendors across ten urban sites in Kenya and analyze aflatoxin levels in commercial samples. Samples were obtained every two months from February-December 2021 and 1255 samples in total were analyzed. Almost all samples (97%) showed detectable levels of aflatoxin, with 16% of tested samples exceeding the national regulatory limit of 10 ppb. Mean contamination levels are significantly higher (p < 0.001) in informal market samples (9.9 ppb) than in packaged flour in the formal sector (4.9 ppb). We find important seasonal variation in aflatoxin levels, which are highest in our June sample and lowest in December, which we attribute to variation in sourcing of maize grain. Our results demonstrate the need for policy interventions to reduce aflatoxin exposure in Kenya and demonstrate the utility of coordinated monitoring efforts to track levels of food safety risk in low-income settings.

Indexed as

AflatoxinsFlourFood ContaminationZea maysHumansKenyaAflatoxins

Identifiers

PMID41231873
PMCPMC12614574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.